Page last updated: 2024-11-06

heptafluorobutyric anhydride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Heptafluorobutyric anhydride (HFBA) is a highly reactive reagent widely used in organic synthesis, particularly in the preparation of fluorinated compounds. It is a colorless liquid with a pungent odor and is typically synthesized through the reaction of heptafluorobutyryl chloride with heptafluorobutyric acid. Its high reactivity stems from the electron-withdrawing nature of the perfluorinated alkyl group, which enhances the electrophilicity of the carbonyl group. HFBA is particularly valuable in Friedel-Crafts acylation reactions, where it effectively introduces heptafluorobutyryl groups into aromatic compounds. Moreover, it finds applications in the synthesis of pharmaceuticals, agrochemicals, and materials science. The high fluorine content of HFBA contributes to its unique properties, such as enhanced lipophilicity and increased metabolic stability. These features make it a desirable reagent in the development of novel drugs and other bioactive molecules. Extensive research focuses on exploring its potential in pharmaceutical synthesis, particularly in the development of new fluorinated drugs with improved bioavailability and pharmacokinetic profiles.'

heptafluorobutyric anhydride: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

heptafluorobutyric anhydride : An acyclic carboxylic anhydride that is perfluorinated butyric anhydride. It is used as a derivatising reagent for gas chromatographic analyses. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID67643
CHEBI ID39424
SCHEMBL ID207310
MeSH IDM0051397

Synonyms (39)

Synonym
2,2,3,3,4,4,4-heptafluorobutanoic anhydride
c8f14o3
heptafluorobutanoic anhydride
heptafluorobutyric anhydride
heptafluorobutyric anhydride, for gc derivatization, >=99.0%
CHEBI:39424
336-59-4
heptafluorobutyric anhydride, >=98%
AKOS000310053
2,2,3,3,4,4,4-heptafluorobutanoyl 2,2,3,3,4,4,4-heptafluorobutanoate
FT-0660656
H0337
perfluorobutyric anhydride
butanoic acid, heptafluoro-, anhydride
butanoic acid, 2,2,3,3,4,4,4-heptafluoro-, 1,1'-anhydride
h5l67kpx9z ,
unii-h5l67kpx9z
einecs 206-410-8
heptafluorobutyric acid anhydride
FT-0626907
GC10217
SCHEMBL207310
CS-B0897
heptafluoro-n-butyric anhydride
1,1,2,2,3,3,3-heptafluorobutanoic anhydride #
J-521428
mfcd00000432
J-019286
BCP22497
perfluorobutanoic anhydride
DTXSID10861881
Q27119860
FS-4009
AMY39378
D78366
2,2,3,3,4,4,4-heptafluorobutanoicanhydride
1-(4-chlorobenzenesulfonyl)-3,3-dimethylbutane-2-one
butyric acid, heptafluoro-, anhydride
heptafluorobutyryl anhydride

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
chromatographic reagentA reagent used to improve selectivity in chromatographic analyses or separations, e.g. by formation of a derivative or by modification of the mobile phase.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
organofluorine compoundAn organofluorine compound is a compound containing at least one carbon-fluorine bond.
acyclic carboxylic anhydride
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (54)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (25.93)18.7374
1990's22 (40.74)18.2507
2000's8 (14.81)29.6817
2010's8 (14.81)24.3611
2020's2 (3.70)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.13 (24.57)
Research Supply Index4.14 (2.92)
Research Growth Index4.48 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.64%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other60 (98.36%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]